These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 26276768)
21. Clinicopathological differences between T-lymphoblastic leukemia/lymphoma, early T-precursor lymphoblastic leukemia/lymphoma, and mixed-phenotype acute leukemia with T lineage: An analysis of 41 adult cases. Takahashi Y; Kaimi Y; Taniguchi H; Ochi T; Makino H; Makita S; Iwaki N; Fukuhara S; Munakata W; Izutsu K; Maeshima AM Hum Pathol; 2024 Aug; 150():78-85. PubMed ID: 38945375 [TBL] [Abstract][Full Text] [Related]
22. Genomic Landscape of Mixed-Phenotype Acute Leukemia. Hennawi M; Pakasticali N; Tashkandi H; Hussaini M Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232559 [TBL] [Abstract][Full Text] [Related]
23. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079 [TBL] [Abstract][Full Text] [Related]
24. Peripheral blood flow cytometry for the diagnosis of pediatric acute leukemia: Highly reliable with rare exceptions. Cheng J; Klairmont MM; Choi JK Pediatr Blood Cancer; 2019 Jan; 66(1):e27453. PubMed ID: 30255571 [TBL] [Abstract][Full Text] [Related]
25. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia. Mumme HL; Raikar SS; Bhasin SS; Thomas BE; Lawrence T; Weinzierl EP; Pang Y; DeRyckere D; Gawad C; Wechsler DS; Porter CC; Castellino SM; Graham DK; Bhasin M Genome Med; 2023 Oct; 15(1):83. PubMed ID: 37845689 [TBL] [Abstract][Full Text] [Related]
26. An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL). Khan M; Siddiqi R; Naqvi K Ann Hematol; 2018 Jun; 97(6):945-953. PubMed ID: 29546454 [TBL] [Abstract][Full Text] [Related]
27. An unusual case of acute leukemia. Fleury C; Passet M; Settegrana C; Simon L; Chapiro E; Trinquand A; Safra Zaghouani I; Uzunov M; Le Garff-Tavernier M; Armand M; Costopoulos M Ann Biol Clin (Paris); 2017 Jun; 75(3):339-347. PubMed ID: 28540857 [TBL] [Abstract][Full Text] [Related]
29. [Comparison of EGIL1998 and WHO2008 criteria for the diagnosis of mixed phenotype acute leukemia]. Ye L; Lin D; Mi YC; Zhang J; Wang Y; Wang HJ; Wei H; Liu BC; Zhou CL; Li W; Wang JX Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):286-90. PubMed ID: 22781719 [TBL] [Abstract][Full Text] [Related]
30. Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia. Porwit A; Béné MC Cytometry B Clin Cytom; 2019 May; 96(3):183-194. PubMed ID: 31033213 [TBL] [Abstract][Full Text] [Related]
31. Mixed-phenotype acute leukemia: historical overview and a new definition. Weinberg OK; Arber DA Leukemia; 2010 Nov; 24(11):1844-51. PubMed ID: 20844566 [TBL] [Abstract][Full Text] [Related]
33. [Immunophenotyping of 222 children with acute leukemia by multi-color flow cytometry]. Shen HQ; Tang YM; Yang SL; Qian BQ; Song H; Shi SW; Xu WQ Zhonghua Er Ke Za Zhi; 2003 May; 41(5):334-7. PubMed ID: 14751050 [TBL] [Abstract][Full Text] [Related]
34. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia. Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434 [TBL] [Abstract][Full Text] [Related]
35. Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West India. Rai V; Brahmbhatt B; Saha A; Thayakaran IP Indian J Pathol Microbiol; 2024; 67(1):121-127. PubMed ID: 38358200 [TBL] [Abstract][Full Text] [Related]
36. Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11)(p12;q23);MLL-MLLT10. Lou Z; Zhang CC; Tirado CA; Slone T; Zheng J; Zaremba CM; Oliver D; Chen W Leuk Res; 2010 Aug; 34(8):1107-9. PubMed ID: 20299091 [TBL] [Abstract][Full Text] [Related]
37. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes. Takahashi K; Wang F; Morita K; Yan Y; Hu P; Zhao P; Zhar AA; Wu CJ; Gumbs C; Little L; Tippen S; Thornton R; Coyle M; Mendoza M; Thompson E; Zhang J; DiNardo CD; Jain N; Ravandi F; Cortes JE; Garcia-Manero G; Kornblau S; Andreeff M; Jabbour E; Bueso-Ramos C; Takaori-Kondo A; Konopleva M; Patel K; Kantarjian H; Futreal PA Nat Commun; 2018 Jul; 9(1):2670. PubMed ID: 29991687 [TBL] [Abstract][Full Text] [Related]
38. [Immunophenotypic Features and Clinical Prognosis of Patients with Mixed Phenotype Acute Leukemia]. Liu TQ; Huang S; Li XY; Li BX; Yao B; Zhang R; Wang Y; Liu ZQ; Hu KX; Cai B; Yu CL; Qiao JH; Guo M Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1305-1310. PubMed ID: 36208227 [TBL] [Abstract][Full Text] [Related]
39. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. Thalhammer-Scherrer R; Mitterbauer G; Simonitsch I; Jaeger U; Lechner K; Schneider B; Fonatsch C; Schwarzinger I Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077 [TBL] [Abstract][Full Text] [Related]